Concordia Healthcare Corp (CXR) Price Target Lowered to C$7.00 at TD Securities
Concordia Healthcare Corp (TSE:CXR) had its price objective cut by investment analysts at TD Securities from C$14.00 to C$7.00 in a research report issued on Monday. The firm presently has a “hold” rating on the stock. TD Securities’ price objective would suggest a potential downside of 1.69% from the company’s current price.
A number of other equities research analysts have also recently weighed in on the company. Royal Bank Of Canada reiterated an “outperform” rating on shares of Concordia Healthcare Corp in a research note on Tuesday, June 7th. Goldman Sachs Group Inc. set a C$34.00 price objective on Concordia Healthcare Corp in a research note on Friday, July 22nd. Finally, CIBC cut Concordia Healthcare Corp from a “sector perform” rating to an “underperform” rating in a research note on Monday, August 15th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and two have issued a buy rating to the company. The company has a consensus rating of “Hold” and a consensus price target of C$29.00.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/19/concordia-healthcare-corp-cxr-price-target-lowered-to-c7-00-at-td-securities.html
Shares of Concordia Healthcare Corp (TSE:CXR) traded down 4.92% on Monday, reaching $6.77. The company’s stock had a trading volume of 1,033,781 shares. The company has a 50 day moving average of $13.53 and a 200 day moving average of $28.73. Concordia Healthcare Corp has a 1-year low of $6.33 and a 1-year high of $28.35. The stock’s market capitalization is $345.39 million.
Receive News & Ratings for Concordia Healthcare Corp Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Concordia Healthcare Corp and related companies with MarketBeat.com’s FREE daily email newsletter.